Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Probable Alzheimer Disease”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00766363
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System Diseases
FORUM Pharmaceuticals Inc 49
Large-scale testing (Phase 3)Study completedNCT00236431
What this trial is testing

Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,063
Large-scale testing (Phase 3)Study completedNCT00099242
What this trial is testing

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia, Alzheimer Type
Novartis Pharmaceuticals 1,040
Early research (Phase 1)Study completedNCT03587649
What this trial is testing

Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss

Who this might be right for
Alzheimer DiseaseParkinson DiseaseHealthy Volunteers
Invicro 12
Large-scale testing (Phase 3)Study completedNCT00261573
What this trial is testing

The Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

Who this might be right for
Alzheimer DiseaseVascular Dementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 593
Early research (Phase 1)Study completedNCT01035164
What this trial is testing

Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers

Who this might be right for
Positron-Emission TomographyAlzheimer's Disease
Bayer 25
Testing effectiveness (Phase 2)Study completedNCT03069014
What this trial is testing

Study of LM11A-31-BHS in Mild-moderate AD Patients

Who this might be right for
Mild to Moderate Alzheimer's Disease
PharmatrophiX Inc. 242
Large-scale testing (Phase 3)Study completedNCT00428389
What this trial is testing

Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 262
Testing effectiveness (Phase 2)Study completedNCT00142805
What this trial is testing

Tricaprilin in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cerecin 152
Post-approval studies (Phase 4)Study completedNCT01921972
What this trial is testing

The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Charite University, Berlin, Germany 232
Testing effectiveness (Phase 2)Study completedNCT00911807
What this trial is testing

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ever Neuro Pharma GmbH 217
Large-scale testing (Phase 3)WithdrawnNCT04187547
What this trial is testing

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Who this might be right for
Alzheimer's Disease
Cerecin
Large-scale testing (Phase 3)Study completedNCT00236574
What this trial is testing

Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 974
Testing effectiveness (Phase 2)Study completedNCT02813070
What this trial is testing

Comparison of PET Amyloid Imaging in Japanese and Western Subjects

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseHealthy
GE Healthcare 70
Testing effectiveness (Phase 2)Study completedNCT01073228
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 409
Testing effectiveness (Phase 2)Study completedNCT00785759
What this trial is testing

Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers

Who this might be right for
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
GE Healthcare 78
Early research (Phase 1)Study completedNCT03545789
What this trial is testing

Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

Who this might be right for
Healthy VolunteersAlzheimer DiseaseProgressive Supranuclear Palsy
Invicro 16
Large-scale testing (Phase 3)Study completedNCT00219232
What this trial is testing

An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis 868
Large-scale testing (Phase 3)Study completedNCT04669028
What this trial is testing

NE3107 in Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
BioVie Inc. 439
Testing effectiveness (Phase 2)Ended earlyNCT01117948
What this trial is testing

Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.

Who this might be right for
Alzheimer´s Disease
JSW Lifesciences 219
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation